Anti-LEMD2 antibodies are used in the immunodetection of the protein LEM domain nuclear envelope protein 2. In humans, the canonical protein has a reported length of 503 amino acid residues and a mass of 57 kDa. Its subcellular localization is in the nucleus and cytoplasm. Up to 2 different isoforms have been reported for this protein. It is notably widely expressed in many tissue types. LEMD2 is known to be involved with skeletal muscle cell differentiation. Post-translational modifications have been described, including phosphorylation. The LEMD2 gene has been associated with the disease, Cataracts. Synonyms for this target antigen include LEM domain containing 2, hLEM2, lamina-associated polypeptide-emerin-MAN1 domain containing 2, and LEM domain-containing protein 2. LEMD2 gene orthologs have been reported in the mouse, rat, bovine, chimpanzee and chicken species. A number of LEMD2 antibodies have been mentioned in research publications and have associated citations. Western Blot is a widely used application for these antibodies. ELISA, Immunocytochemistry, and Immunofluorescence are also common applications.